Postacute Ischemia Vascular Endothelial Growth Factor Transfer by Transferrin-Targeted Liposomes Attenuates Ischemic Brain Injury After Experimental Stroke in Rats
Authors:
- 2 December 2010
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 22 (2) , 207-215
Abstract
Our objective was to achieve the enhanced delivery of vascular endothelial growth factor (VEGF) to ischemically disordered brain through transferrin-coupled liposomes (Tf-PLs) via intravenous administration, and to observe the effect of Tf-VEGF-PLs on ischemic brain neuroprotection and angiogenesis. Cerebral VEGF overexpression was achieved with Tf-PLs by intravenous injection 48 hr after an acute stroke. β-Galactosidase expression was monitored; saline was injected as a control. The success of postischemic gene transduction was confirmed by β-galactosidase staining and by increased VEGF mRNA and protein in ischemic brain. Vascular density, neurological recovery, and ischemic area calculation were performed to evaluate the effect of Tf-VEGF-PLs. The positive expression of β-galactosidase indirectly indicated that VEGF was successfully delivered into brain by Tf-VEGF-PLs. VEGF mRNA in the Tf-VEGF-PL group 24 hr after injection was significantly higher than in the control group ( p < 0.05). Western blot analysis showed that postischemic Tf-VEGF-PLs resulted in increased VEGF protein levels compared with VEGF-PLs and saline-administered rats ( p < 0.05) 48 hr after administration. At 21 days after drug injection, we observed a significant decrease in infarct volume and better neurological function in the Tf-VEGF-PL-treated group, compared with the VEGF-PL group. FITC–dextran marking showed increased vascular density in the penumbra of Tf-VEGF-PL-treated hemispheres (245,873.9, number of microvessels per field) compared with that in VEGF-PL-treated hemispheres (139,801.3) or saline-treated hemispheres (102,175.5) ( p < 0.05). The remainder of the cerebral blood flow after ischemia in the Tf-VEGF-PL group was significantly more than in the control groups (0.35 vs. 0.29, 0.21; p < 0.05). We conclude that the VEGF gene can be delivered noninvasively into the brain by Tf-VEGF-PLs. Postischemic treatment with Tf-VEGF-PLs effectively promoted neuroprotection and vascular regeneration in the chronic stage of cerebral infarction.Keywords
This publication has 36 references indexed in Scilit:
- Implications of Vascular Endothelial Growth Factor for Postischemic Neurovascular RemodelingJournal of Cerebral Blood Flow & Metabolism, 2009
- Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemiaNeuroscience Research, 2005
- Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivoInternational Journal of Pharmaceutics, 2004
- Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermiaCancer Letters, 2004
- Transferrin/transferrin receptor‐mediated drug deliveryMedicinal Research Reviews, 2002
- Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in RatsStroke, 2001
- Delayed, but Marked, Expression of Apolipoprotein E is Involved in Tissue Clearance after Cerebral InfarctionJournal of Cerebral Blood Flow & Metabolism, 2001
- Treatment of stroke in rat with intracarotid administration of marrow stromal cellsNeurology, 2001
- Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in RatsStroke, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976